CLIMB Act, DOJ Rescheduling Delays & Medicare’s Full-Spectrum CBD Rules | Cannabis Legalization News

Tom hosts another episode of Cannabis Legalization News, recapping the week’s major policy and market developments. The show covers the newly introduced bipartisan CLIMB Act (Capital Lending and Investment for Marijuana Businesses Act), which would provide safe harbor for U.S. stock exchanges and market participants to list and trade cannabis-related securities. They discuss reports that “Pot Inc.” is poised to benefit from President Trump’s marijuana reclassification directive, but that DOJ—under Pam Bondi—has no deadline and is still working through a complicated internal process, while rescheduling alone won’t create a full regulatory framework. The episode also reviews CMS/Medicare guidance moving toward coverage of certain hemp-derived full-spectrum CBD edibles with strict limits (under 3 mg THC per serving, later tightening), benefiting companies like Charlotte’s Web. Additional topics include a CRS rescheduling update, state-level restrictions, Virginia adult-use timing, dispensary build-out/financing realities, and cannabis marketing limits.

00:00 Welcome and Week Ahead
02:01 Climb Act Wall Street Access
03:50 Politics Gas and Gripes
05:06 Trump Reclassification Watch
06:55 CMS Hemp CBD Rules
09:35 Charlotte's Web Stock Surge
12:41 CRS Rescheduling Update
16:42 State Markets and Homegrow
20:46 DEA Data Youth Use Down
22:45 State Legislation Virginia Focus
26:40 Ballot Rules Block Legalization
28:13 Verano Loan Breakdown
29:54 Building a Brand Lounge
31:09 Amazon Style Ad Revenue
32:08 Regulatory Steps and Loans
32:44 Wisconsin Hemp Guardrails
33:54 Why Dispensaries Take Years
37:43 Strain Talk Ridgeline Runtz
39:18 AI Tools and Weed Blog
42:08 Interstate Commerce and Branding
45:15 Pricing Menus and Market Fit
46:53 Missouri Expansion and Exit Strategy
48:36 Wrap Up and Legal Sponsor